Reply to comments on "A scoping review on cannabidiol therapy in tuberous sclerosis: Current evidence and perspectives for future development"

Epilepsy Behav. 2022 Apr 29;131(Pt A):108704. doi: 10.1016/j.yebeh.2022.108704. Online ahead of print.

NO ABSTRACT

PMID:35500511 | DOI:10.1016/j.yebeh.2022.108704